Category

This is an example page of categories. If you have a long list of courses, you can display them via the LearnDash category feature.

Free Courses Category

Inflammation: More Than Skin Deep in Psoriasis

CMEO Medical Meeting

Symposium Date/Time: Wednesday, November 16, 2016
5:15 PM – 6:45 PM
New York Academy of Medicine, New York, NY

This activity offers CE credit for:

  1. Physicians (CME)
  2. Nurses (CNE)
  3. Pharmacists (ACPE)
  4. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Thursday, November 16, 2017

Faculty

 

James G. Krueger, MD, PhD James G. Krueger, MD, PhD
D. Martin Carter Professor in Clinical Investigation
Head of Laboratory for Investigative Dermatology
Co-director, Center for Clinical and Translational Science
The Rockefeller University Hospital
New York, NY

 

Joel M. Gelfand, MD, MSCE Joel M. Gelfand, MD, MSCE
Professor of Dermatology
Professor of Epidemiology
Vice Chair of Clinical Research and Medical Director
Dermatology Clinical Studies Unit
Director, Psoriasis and Phototherapy Treatment Center
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

 

Iain B. McInnes, FRCP, PhD, FRSE Iain B. McInnes, FRCP, PhD, FRSE
Muirhead Chair of Medicine
Director, Institute of Infection, Immunity and Inflammation
Professor of Experimental Medicine
Director of Research Institute
(Immunology)
College of Medical, Veterninary and Life Sciences
University of Glasgow
Glasgow, Scotland
United Kingdom

 

Statement of Need

Individuals with psoriasis are at significant risk for psoriatic arthritis (PsA) and cardiovascular disease (CVD). Dermatologists treat the majority of patients with psoriasis and have an important role in screening for these disorders and effectively treating psoriasis according to the underlying inflammation.

However, gaps have been identified related to recognition of common pathogenic links between psoriasis and PsA, the awareness of the role of inflammatory cytokines and cellular mediators in the pathogenesis of psoriasis and CVD, and how treatment selection is impacted by the inflammatory mechanism of psoriasis.

This 90-minute symposium features expert faculty presenting the latest evidence and highlighting the mechanisms that link inflammatory disease to adverse cardiovascular outcomes. Faculty will explore current treatment paradigms for moderate to severe psoriasis and psoriatic arthritis and translate the evidence through patient vignettes.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Recognize the common pathogenic links between psoriasis and PsA to improve assessment and diagnosis in practice.
  • Illustrate the role of inflammatory cytokines and cellular mediators in the pathogenesis of psoriasis and CVD.
  • Integrate the role of treatment targets/pathways of new agents into treatment decisions for patients with psoriasis and PsA.

The following learning objectives pertain only to those requesting CNE credit:

  • Identify ways to integrate the role of treatment targets/pathways of new agents into treatment decisions for patients with psoriasis and PsA.

Financial Support

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Target Audience

Dermatologists, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare providers with an interest in psoriasis.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.

CPE Credit (Pharmacists):
ACPECME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs)

Universal Activity Number: 0376-0000-16-029-L01-P

Type: knowledge-based

Successful completion of this CE activity includes participating in the live activity, reviewing the course materials, within 30 days of completion of the activity, and completing your activity evaluation and post-test online (75% pass rate required). You may print your certificate or statement of credit immediately. Please visit www.CMEOutfitters.com/20162(requires free account activation).

Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Krueger has disclosed that he has received research and grant support from Amgen Inc.; Boehringer Ingelheim; Bristol-Myers Squibb Company; Dermira, Inc.; Innovaderm Research Inc.; Janssen Pharmaceuticals, Inc.; Kadmon Corporation, LLC; Kyowa Hakko Kirin Co., Ltd.; LEO Pharma Inc.; Novartis; PAREXEL International Corporation; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; and Vitae Pharmaceuticals, Inc. He serves as a consultant for AbbVie Inc.; Baxter; Biogen Idec; Boehringer Ingelheim; Bristol-Myers Squibb Company; Dermira, Inc.; Janssen Pharmaceuticals, Inc.; Kadman Corporation, LLC; Kineta, Inc.; Eli Lilly and Company, Merck & Co.. Inc.; Novartis; Pfizer Inc.; sanofi-aventis U.S. LLC; EMD Serono, Inc.; and XenoPort, Inc.

Dr. Gelfand has disclosed that he has received research and grant support from AbbVie Inc.; Amgen Inc.; Eli Lilly and Company; Janssen Biologics, Inc. (formerly Centocor Biotech, Inc.); Novartis Corporation; Pfizer Inc.; Regeneron Pharmaceuticals, Inc; and Sanofi. He serves as a consultant for AbbVie Inc.; Amgen Inc.; AstraZeneca; Celgene Corporation; Coherus Biosciences; Eli Lilly and Company; Janssen Biologics, Inc. (formerly Centocor Biotech, Inc.); Merck & Co., Inc.; Novartis Pharmaceuticals Corporation;Pfizer Inc.; Sanofi; and Valeant.

Dr. McInnes has disclosed that he has received research and grant support from Arthritis Research UK (ARUK) Centre of Excellence; Celgene Corporation; and UCB, Inc.. He serves as a consultant for AbbVie Inc.; AstraZeneca; Bristol-Myers Squibb Company; Celgene Corporation; Eli Lilly and Company; Janssen Pharmaceuticals, Inc.; Novartis; Pfizer, Inc.; and UCB, Inc.

Jeffrey Helfand, DO, MS (peer reviewer) has nothing to disclose.

Kimberley Murray, RN, MS (peer reviewer) has nothing to disclose.

Sharon Tordoff, CHCP (planning committee) has nothing to disclose.

Jan Perez, CHCP (planning committee) has nothing to disclose.

Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to disclose.

CME Outfitters, LLC, the faculty, and Lilly do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

Bringing Health Care Providers Together to Diagnose and Treat Idiopathic Pulmonary Fibrosis

featured_tv092

CMEO Live and On Demand

Premiere Date: Wednesday, January 18, 2017
Live Broadcast: 12:00–1:30 p.m. ET
Taped Re-Air: 4:00–5:30 p.m. ET
This activity offers CE credit for:
Physicians (CME)
Nurses (CNE)
Pharmacists (ACPE)
Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Thursday, January 18, 2018
Faculty

Steven D. Nathan, MD, FCCP
Medical Director, Lung Transplant Program
Director, Advanced Lung Disease Program
Inova Fairfax Hospital
Professor of Medicine
Virginia Commonwealth University, Inova Fairfax Campus
Falls Church, VA

Statement of Need

Although the most common of the restrictive lung diseases, idiopathic pulmonary fibrosis (IPF) is a rare but deadly disease, affecting an estimated 6.8 to 42.7 per 100,000 people, with higher rates in those older than 65 years, and resulting in approximately 40,000 deaths annually in the United States.1

Education to community pulmonologists, radiologists, and primary care physicians, as well as the multidisciplinary team is important to increase knowledge related to recognition and diagnosis. Clinicians need to be aware of when to refer patients with potential IPF to specialty centers with pulmonologists, radiologists, and pathologists specialized in interstitial lung disease (ILD). All providers in the multidisciplinary and multispecialty treatment team need education related to recent ATS/ERS/JRS/ALAT guidelines and mechanisms of action for the approved treatments for IPF.

Baseline data of self-reported gaps in care and skills in recognition, referral, and treatment of IPF will be at the forefront of this CME Outfitters Live and On Demand. Expert faculty will highlight the latest evidence and guidelines for IPF including when to refer and best treatment approach.

Reference:
1. Raghu G, Chen SY, Yeh WS, et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11. Lancet Respir Med. 2014;2(7):566-572. Accessed November 1, 2016.

Learning Objectives

At the end of this CE activity, participants should be able to:
Identify the signs and symptoms of idiopathic pulmonary fibrosis.
Outline the red flags that would trigger an expeditious referral of a patient with dyspnea to a multidisciplinary team.
Combine information derived from guidelines and studies of newly approved and emerging therapies in identifying a treatment approach for the patient with IPF.
Financial Support

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Supported by an educational grant from Genentech.

Target Audience

Pulmonologists, radiologists, primary care physicians, physician assistants, nurse practitioners, nurses, pharmacists and other healthcare providers interested in idiopathic pulmonary fibrosis.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.5 contact hours

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.5 contact hours of pharmacotherapeutic contact hours.

CPE Credit (Pharmacists):
ACPE CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.5 contact hours (0.15 CEUs) Universal Activity Number:
0376-0000-17-001-H01-P (enduring material)
0376-0000-17-001-L01-P (live program)

Type: knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST20184 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Steven D. Nathan, MD, FCCP has disclosed that he receives research support from Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./Roche. He is a member of the speakers bureau for Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./Roche. He is a consultant for Boehringer Ingelheim Pharmaceuticals, Inc.; Genentech, Inc./Roche.

Disclosures were obtained from the CME Outfitters, LLC staff: Nothing to Disclose

Daniela V. DiBiase, MS (planning committee) has no disclosures to report.

Jan Perez, CCHP (planning committee) has no disclosures to report.

Sharon Tordoff, CCHP (planning committee) has no disclosures to report.

Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

CME Outfitters, LLC, the faculty, Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

This document was last modified on: 11/15/2016 14:40:06
TV-092-011817-90

Free LearnDash Course Example


Free Course Demo Image

Course Description

This is an example of a free course consisting of lessons, topics and quizzes. There is one assessment-style quiz and one final exam. Read more.


Paid Courses Category

How to Play Piano for Beginners


Paid Course Demo Image

Course Description

This is a course featuring a sample lesson. The sample lesson is available for free, to anyone creating an account. To take the sample lesson, simply click on the first lesson link below. The remaining course content will be shown only if the visitor decides to purchase the course. Read more.